Research Peptides

Research peptides UK we stock

• BPC-157 (5 mg and 10 mg) – A synthetic 15-amino-acid peptide derived from a gastric protein sequence.
• TB-500 (5 mg and 10 mg) – Synthetic thymosin beta-4 peptide used in cell-migration, actin-dynamics and tissue-repair research.
• BPC-157 + TB-500 Blend (10 mg (5 + 5) and 20 mg (10 + 10)) – BPC-157 and TB-500 in equal parts, co-lyophilised in a single vial.
• CJC-1295 (no DAC) (5 mg and 10 mg) – Modified GRF (1-29).
• CJC-1295 + Ipamorelin Blend (10 mg (5 + 5)) – CJC-1295 (no DAC) and Ipamorelin, 5 mg each in one vial.
• Ipamorelin (10 mg) – A selective pentapeptide ghrelin-receptor (GHS-R1a) agonist used in growth-hormone secretion research.
• Tesamorelin (10 mg and 20 mg) – A stabilised 44-amino-acid GHRH analogue.
• IGF-1 LR3 (1 mg) – Long R3 insulin-like growth factor-1: an 83-amino-acid IGF-1 analogue with reduced binding-protein affinity, widely used in cell culture.
• HGH Fragment 176-191 (10 mg) – The C-terminal 16-amino-acid fragment of human growth hormone, studied in lipid-metabolism research without the IGF-1 effects of full GH.
• AOD-9604 (10 mg) – A modified C-terminal fragment of human growth hormone (Tyr-hGH 177-191) studied in fat-metabolism research.
• 5-Amino-1MQ (10 mg) – A small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), used in cellular metabolism and NAD⁺ research.
• MOTS-c (10 mg and 40 mg) – A 16-amino-acid mitochondrial-derived peptide studied in metabolic and ageing research.
• SLU-PP-332 (5 mg) – A synthetic pan-agonist of the estrogen-related receptors (ERRα/β/γ), studied as an “exercise mimetic” in mitochondrial research.
• SS-31 (Elamipretide) (10 mg and 50 mg) – A cell-permeable, mitochondria-targeting tetrapeptide that binds cardiolipin in the inner mitochondrial membrane.
• NAD+ (500 mg and 1000 mg) – Research-grade nicotinamide adenine dinucleotide.
• Epithalon (10 mg and 50 mg) – The synthetic tetrapeptide Ala-Glu-Asp-Gly (Epitalon), studied in telomerase and pineal research.
• FOXO4-DRI (10 mg) – A D-retro-inverso peptide that disrupts the FOXO4–p53 interaction.
• Glutathione (1500 mg) – Reduced L-glutathione (GSH), the cell's main thiol antioxidant tripeptide, in a 1500 mg research vial.
• GHK-Cu (50 mg and 100 mg) – The copper(II) complex of the tripeptide glycyl-histidyl-lysine.
• Glow Blend (70 mg) – GHK-Cu, BPC-157 and TB-500 co-lyophilised in one 70 mg vial.
• KLOW Blend (80 mg) – GHK-Cu, KPV, BPC-157 and TB-500 in one 80 mg vial.
• KPV (10 mg) – The C-terminal tripeptide of α-MSH (Lys-Pro-Val), studied for anti-inflammatory signalling in gut and skin models.
• Selank (10 mg) – A synthetic heptapeptide analogue of tuftsin, studied in anxiety and GABAergic signalling models.
• Semax (10 mg) – A heptapeptide analogue of ACTH (4-10), studied for BDNF expression and neuroprotection in animal models.
• DSIP (10 mg) – Delta sleep-inducing peptide.
• PT-141 (Bremelanotide) (10 mg) – A cyclic heptapeptide melanocortin-receptor agonist (MC3R/MC4R), derived from Melanotan II.
• Kisspeptin-10 (5 mg and 10 mg) – The shortest biologically active kisspeptin (metastin 45-54), a KISS1R agonist used in reproductive-axis research.

Quality you can check

Every compound in our research peptides UK collection is supplied at ≥99% purity by HPLC. Batches are analysed by independent laboratories and the certificates are published on our lab reports page. Each vial is lyophilised, sealed and kept cold until dispatch.

Delivery and payment

All research peptides UK orders ship from the UK by Royal Mail Tracked 48 – £4.99, or free with a storage box over £100. Pay by UK bank transfer or crypto; we never ask for card details.

All products are for in vitro laboratory research only. Not for human or veterinary use.